Thomas Urup

5PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Sensory systemsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 31, 2026
Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment.

|Sep 10, 2026
[18F]FET PET imaging for early response assessment of bevacizumab in recurrent glioblastoma.

|Jun 27, 2025
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapy.

Shivani Chiranth, Vincent Fougner, Ib Jarle Christensen

|Sep 14, 2023
A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis.

Shivani Chiranth, Seppo W Langer, Hans Skovgaard Poulsen

|Mar 06, 2020
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.

Thomas Urup, Linn Gillberg, Katja Kaastrup

Pageof 1

Frequent Collaborators

3 joint publications

Hans Skovgaard Poulsen

3 joint publications

Benedikte Hasselbalch

2 joint publications

Shivani Chiranth

1 joint publications

Seppo W Langer